BOUT vs. BAPR
Compare and contrast key facts about Innovator IBD Breakout Opportunities ETF (BOUT) and Innovator U.S. Equity Buffer ETF - April (BAPR).
BOUT and BAPR are both exchange-traded funds (ETFs), meaning they are traded on stock exchanges and can be bought and sold throughout the day. BOUT is a passively managed fund by Innovator that tracks the performance of the IBD Breakout Stocks Total Return Index. It was launched on Sep 13, 2018. BAPR is a passively managed fund by Innovator that tracks the performance of the Cboe S&P 500 Buffer Protect Index April. It was launched on Mar 29, 2019. Both BOUT and BAPR are passive ETFs, meaning that they are not actively managed but aim to replicate the performance of the underlying index as closely as possible.
Performance
BOUT vs. BAPR - Performance Comparison
Loading graphics...
BOUT vs. BAPR - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|---|---|
BOUT Innovator IBD Breakout Opportunities ETF | 8.23% | -6.77% | 18.82% | 13.27% | -22.60% | 22.69% | 50.56% | 3.05% |
BAPR Innovator U.S. Equity Buffer ETF - April | 2.08% | 8.28% | 15.95% | 23.16% | -7.04% | 12.58% | 6.19% | 10.49% |
Returns By Period
In the year-to-date period, BOUT achieves a 8.23% return, which is significantly higher than BAPR's 2.08% return.
BOUT
- 1D
- 2.67%
- 1M
- -3.79%
- YTD
- 8.23%
- 6M
- 1.15%
- 1Y
- 8.69%
- 3Y*
- 8.84%
- 5Y*
- 4.03%
- 10Y*
- —
BAPR
- 1D
- 2.58%
- 1M
- 0.99%
- YTD
- 2.08%
- 6M
- 4.42%
- 1Y
- 15.33%
- 3Y*
- 13.43%
- 5Y*
- 10.13%
- 10Y*
- —
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
BOUT vs. BAPR - Expense Ratio Comparison
BOUT has a 0.80% expense ratio, which is higher than BAPR's 0.79% expense ratio.
Return for Risk
BOUT vs. BAPR — Risk / Return Rank
BOUT
BAPR
BOUT vs. BAPR - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Innovator IBD Breakout Opportunities ETF (BOUT) and Innovator U.S. Equity Buffer ETF - April (BAPR). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| BOUT | BAPR | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 0.40 | 1.29 | -0.89 |
Sortino ratioReturn per unit of downside risk | 0.66 | 1.99 | -1.33 |
Omega ratioGain probability vs. loss probability | 1.09 | 1.40 | -0.31 |
Calmar ratioReturn relative to maximum drawdown | 0.65 | 1.74 | -1.08 |
Martin ratioReturn relative to average drawdown | 1.81 | 11.59 | -9.77 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading graphics...
Sharpe Ratios by Period
| BOUT | BAPR | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 0.40 | 1.29 | -0.89 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.21 | 0.88 | -0.67 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.30 | 0.75 | -0.45 |
Correlation
The correlation between BOUT and BAPR is 0.68, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.
Dividends
BOUT vs. BAPR - Dividend Comparison
BOUT's dividend yield for the trailing twelve months is around 0.32%, while BAPR has not paid dividends to shareholders.
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|---|---|---|
BOUT Innovator IBD Breakout Opportunities ETF | 0.32% | 0.34% | 0.60% | 1.32% | 1.35% | 0.00% | 0.00% | 0.00% | 0.22% |
BAPR Innovator U.S. Equity Buffer ETF - April | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Drawdowns
BOUT vs. BAPR - Drawdown Comparison
The maximum BOUT drawdown since its inception was -36.75%, which is greater than BAPR's maximum drawdown of -23.91%. Use the drawdown chart below to compare losses from any high point for BOUT and BAPR.
Loading graphics...
Drawdown Indicators
| BOUT | BAPR | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -36.75% | -23.91% | -12.84% |
Max Drawdown (1Y)Largest decline over 1 year | -13.73% | -9.19% | -4.54% |
Max Drawdown (5Y)Largest decline over 5 years | -28.28% | -15.58% | -12.70% |
Current DrawdownCurrent decline from peak | -6.50% | 0.00% | -6.50% |
Average DrawdownAverage peak-to-trough decline | -12.55% | -2.66% | -9.89% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 4.95% | 1.38% | +3.57% |
Volatility
BOUT vs. BAPR - Volatility Comparison
Innovator IBD Breakout Opportunities ETF (BOUT) has a higher volatility of 8.61% compared to Innovator U.S. Equity Buffer ETF - April (BAPR) at 3.45%. This indicates that BOUT's price experiences larger fluctuations and is considered to be riskier than BAPR based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading graphics...
Volatility by Period
| BOUT | BAPR | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 8.61% | 3.45% | +5.16% |
Volatility (6M)Calculated over the trailing 6-month period | 17.18% | 4.26% | +12.92% |
Volatility (1Y)Calculated over the trailing 1-year period | 21.74% | 11.90% | +9.84% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 19.54% | 11.54% | +8.00% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 22.96% | 13.25% | +9.71% |